CAMBRIDGE, Mass., Sept. 26, 2018 /PRNewswire/ -- Infinity
Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at Cantor
Fitzgerald's Global Healthcare Conference on Wednesday, October 3, 2018, at 5:10 p.m. ET at the Intercontinental New York
Barclay Hotel in New York, NY. A
live webcast of the presentation will be available on the
Investors/Media section of Infinity's website at www.infi.com, and
will be available for 30 days following the event.
About Infinity
Infinity is an innovative
biopharmaceutical company dedicated to advancing novel cancer
treatments. Infinity is advancing IPI-549, a potentially
transformative immuno-oncology approach that aims to reprogram
tumor-associated macrophages by selectively inhibiting PI3K-gamma.
A Phase 1/1b study in approximately
200 patients with advanced solid tumors is ongoing. For more
information on Infinity, please refer to Infinity's website at
www.infi.com.
Contact:
Stephanie
Ascher, Stern Investor Relations, Inc.
212-362-1200 or Stephanie@sternir.com
View original
content:http://www.prnewswire.com/news-releases/infinity-to-present-at-cantor-fitzgerald-global-healthcare-conference-300719031.html
SOURCE Infinity Pharmaceuticals, Inc.